GSE130401 trametinib YAP 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE130401_trametinib_YAP_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE130401_trametinib_YAP_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE130401_trametinib_YAP_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE130401_trametinib_YAP_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H19 imprinted maternally expressed transcript

Gene

myocardial infarction associated transcript

Gene

WT1 antisense RNA

Gene

miR-17-92a-1 cluster host gene

Gene

long intergenic non-protein coding RNA 944

Gene

MIR9-1 host gene

Gene

TMEM51 antisense RNA 1

Gene

prostate cancer associated transcript 19

Gene

SLCO5A1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 2623

  • Gene

    H19 imprinted maternally expressed transcript


  • Gene

    myocardial infarction associated transcript


  • Gene

    WT1 antisense RNA


  • Gene

    miR-17-92a-1 cluster host gene


  • Gene

    long intergenic non-protein coding RNA 944



  • Gene

    TMEM51 antisense RNA 1


  • Gene

    prostate cancer associated transcript 19


  • Gene

    SLCO5A1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 2623

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.